ArticleJournal of molecular medicine (Berlin, Germany)2025
Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic intervention.
Akshaya Srikanth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.